Point mutations of the c-H-ras gene in spontaneous liver tumors of transgenic mice carrying the human c-H-ras gene

Toxicologic Pathology

Volumn 26, Issue 4, 1998, Pages 556-561

  Hayashi, Shim Mo ^a   Mori, Ikuo ^a   Nonoyama, Takashi ^a   Mitsumori, Kunitoshi ^b  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Hepatic hemangiosarcoma; Hepatocellular carcinoma; Human prototype c H ras transgenic (rasH2 Tg) mouse; Nonradioactive oligonucleotide dot blot hybridization; Polymerase chain reaction; Single strand conformation polymorphism (PCR SSCP)

Indexed keywords

ANGIOSARCOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOT HYBRIDIZATION; GENE AMPLIFICATION; LIVER CELL CARCINOMA; LIVER TUMOR; MOUSE; NONHUMAN; ONCOGENE H RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0031848163     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339802600412     Document Type: Article

References (27)

1. Ando K, Saitoh A, Hino O, Takahashi R, Kimura M, and Katsuki M (1992). Chemically induced forestomach papillomas in transgenic mice carry mutant human c-H-ras transgenes. Cancer Res. 52: 978-982.
2. Contrera JF, Jacobs C, and DeGeorge JJ (1997). Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals. Regul. Toxicol. Pharmacol. 25: 130-145.
3. Davies TS and Monro A (1995). Marketed human pharmaceuticals reported to be tumorigenic in rodents. J. Am. Coll. Toxicol. 14: 90-107.
4. Doi ST, Kimura M, and Katsuki M (1994). Site-specific mutation of the human c-H-ras transgene induced by dimethylbenzanthracene causes tissue-specific tumors in mice. Jpn. J. Cancer Res. 85: 801-807.
5. Faccini JM, Butler WR, Friedmann JC, Hess R, Reznik GK, Ito N, Hayashi Y, and Williams GM (1992). IFSTP guidelines for the design and interpretation of the chronic rodent carcinogenicity bioassay. Exp. Toxicol. Pathol. 44: 443-456.
6. Fox TR, Schumann AM, Watanabe PG, Yano BL, Maher VM, and McCormick JJ (1990). Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 X C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens. Cancer Res. 50: 4014-4019.
7. Frith CH, Ward JM, and Turusov VS (1994). Tumours of the liver. In: Pathology of Tumours in Laboratory Animals, 2nd ed., VS Turusov and U Mohr (eds). IARC Scientific Publications, Lyon, France, pp. 223-269.
8. Inoue R, Ushijima T, Katami M, Kushida H, Wakabayashi K, Sato H, Asamoto M, Katsuki M, Sugimura T, and Nagao M (1996). Rare activation of the human c-H-ras transgene of mice in hemangioendothelial sarcomas and liver tumors induced by Glu-P-1. Jpn. J. Cancer Res. 87: 583-588.
9. Ito N, Hasegawa R, Imaida K, Hirose M, Shirai T, Tamano S, and Hagiwara A (1997). Medium-term rat liver bioassay for rapid detection of hepatocarcinogenic substances. J. Toxicol. Pathol. 10: 1-11.
10. Lai DY, Baetcke KP, Vu VT, Cotruvo JC, and Eustis SL (1994). Evaluation of reduced protocols for carcinogenicity testing of chemicals: Report of a joint EPA/NIEHS workshop. Regul. Toxicol. Pharmacol. 19: 183-201.
11. Maronpot RR, Fox T, Malarkey DE, and Goldsworthy TL (1995). Mutations in the ras proto-oncogene: Clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology 101: 125-156.
12. Maronpot RR, Haseman JK, Boorman GA, Eustis SE, Rao GN, and Huff JE (1987). Liver lesions in B6C3F1 mice: The National Toxicology Program, experience and position. Arch. Toxicol. Suppl 10: 10-26.
13. Ogawa K, Imaida K, Masui T, Kawabe M, Hasegawa R, Kato K, Ito N, and Shirai T (1996). Chemically induced lung and forestomach neoplasias in transgenic mice carry mutant forms of the human c-Ha-ras transgene. Carcinogenesis 17: 341-345.
14. Organization for Economic Cooperation and Development (1981). Guideline for Testing of Chemicals. Carcinogenicity Studies. Document 451.
15. Richardson KK, Helvering LM, Copple DM, Rexroat MA, Linville DW, Engelhaedt JA, Todd GC, and Richardson FC (1992). Genetic alterations in the 61st codon of the H-ras oncogene isolated from archival sections of hepatic hyperplasias, adenomas and carcinomas in control groups of B6C3F1 mouse bioassay studies conducted from 1979 to 1986. Carcinogenesis 13: 935-941.
16. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, and Erlich HA (1988). Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487-491.
17. Saitoh A, Kimura M, Takahashi R, Yokoyama M, Nomura T, Izawa M, Sekiya T, Nishimura S, and Katsuki M (1990). Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 5: 1195-2000.
18. Shibata D (1994). Extraction of DNA from paraffin-embedded tissue for analysis by polymerase chain reaction: New tricks from an old friend. Hum. Pathol. 25: 561-563.
19. Speid LH, Lumley CE, and Walker SR (1990). Harmonization of guidelines for toxicity testing of pharmaceuticals by 1992. Regul. Toxicol. Pharmacol. 12: 179-211.
20. Stanley LA (1995). Molecular aspects of chemical carcinogenesis: The roles of oncogenes and tumour suppressor genes. Toxicology 96: 173-194.
21. Tennant RW, French JE, and Spalding JW (1995). Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ. Health Perspect. 103: 942-950.
22. Tsunematsu S, Saito H, Kagawa T, Morizane T, Hata J, Nakamura T, Ishii H, Tsuchiya M, Nomura T, and Katsuki M (1994). Hepatic tumors induced by carbon tetrachloride in transgenic mice carrying a human c-H-ras proto-oncogene without mutations. Int. J. Cancer 59: 554-559.
23. Tsunematsu S, Saito H, Tada S, Ebinuma H, Tsuchiya M, Kumagai N, Morizane T, Nomura T, and Ishii H (1997). Susceptibility of experimental autoimmune hepatitis in transgenic mice overexpressing the c-H-ras gene. J. Gastroenterol. Hepatol. 12: 319-324.
24. U.S. Environmental Protection Agency (1986). Guidelines for Carcinogen Risk Assessment. EPA/600/8-82/006F. U.S. Environmental Protection Agency, Washington, D.C.
25. Vries MV, Bogaard ME, van den Elst H, van Boom JH, van der Eb AJ, and Bos JL (1986). A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. Gene 50: 313-320.
26. Yamamoto S, Hayashi Y, Mitsumori K, and Nomura T (1997). Rapid carcinogenicity testing system with transgenic mice harboring human prototype c-HRAS gene. Lab. Anim. Sci. 47: 121-126.
27. Yamamoto S, Mitsumori K, Kodama Y, Matsunuma N, Manabe S, Okamiya H, Suzuki H, Fukuda T, Sakamaki Y, Sunaga M, Nomura G, Hioki K, Wakana S, Nomura T, and Hayashi Y (1996). Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-H-ras gene than in control non-transgenic mice. Carcinogenesis 17: 2455-2461.